Published in TB and Outbreaks Week, November 30th, 2004
According to a study from Greece, "Analysis of data on the incidence of typhoid fever and the costs of vaccination of travelers to the developing world indicates that vaccination may not be cost-effective for travel to countries with a moderate-to-high endemicity. It may be reasonable to selectively vaccinate travelers to countries with a very high incidence of typhoid fever, and particularly those who are visiting relatives or who will be in close contact with the local population."
"Vaccination of travelers on standard tourist itineraries is probably not necessary," said V....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.